metformin has been researched along with 17-alpha-hydroxyprogesterone in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (33.33) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jakubowicz, DJ; Nestler, JE | 1 |
| Utiger, RD | 1 |
| Koivunen, RM; Martikainen, HK; Morin-Papunen, LC; Ruokonen, A | 1 |
| Bayram, F; Keleştimur, F; Sahin, Y; Unlühizarci, K | 1 |
| Arslanian, S; Witchel, SF | 1 |
| Bayram, F; Keleştimur, F; Sahin, Y; Tutuş, A; Unlühizarci, K | 1 |
| Cianci, A; Ciani, A; De Leo, V; Egbe, TO; la Marca, A; Morgante, G; Paglia, T | 1 |
| Caputo, M; Castello, R; Moghetti, P; Muggeo, M; Negri, C; Perrone, F; Tosi, F; Zanolin, E | 1 |
| Attia, GR; Carr, BR; Rainey, WE | 1 |
| Koivunen, RM; Martikainen, HK; Morin-Papunen, LC; Ruokonen, A; Tapanainen, JS | 1 |
| Bendlová, B; Cibula, D; Hill, M; Snajderová, M; Stárka, L; Sulcová, J; Vondra, K; Vrbíková, J | 1 |
| Battaglia, C; Gamba, O; Genazzani, AD; Malavasi, B; Strucchi, C; Tortolani, F | 1 |
| Berker, B; Corapcioglu, D; Demirel, C; Emral, R; Kose, K; Unlu, C | 1 |
| Bahtiyar, G; Sacerdote, AS; Weiss, K | 1 |
| De Cicco, S; Guido, M; Lanzone, A; Proto, C; Romualdi, D; Tagliaferri, V | 1 |
| Ferriani, RA; Japur de Sá Rosa-e-Silva, AC; Nascimento, AD; Reis, RM; Silva Lara, LA | 1 |
| Asenjo, S; Cassorla, F; Codner, E; Eyzaguirre, FC; Iñíguez, G; López, P; Mujica, V; Torrealba, I | 1 |
| Krysiak, R; Okopien, B | 1 |
7 trial(s) available for metformin and 17-alpha-hydroxyprogesterone
| Article | Year |
|---|---|
Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Blood Glucose; Female; Humans; Hydroxyprogesterones; Hyperandrogenism; Hypoglycemic Agents; Insulin; Leuprolide; Luteinizing Hormone; Metformin; Obesity; Polycystic Ovary Syndrome; Steroid 17-alpha-Hydroxylase; Testosterone | 1996 |
Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Blood Glucose; Cohort Studies; Dehydroepiandrosterone; Female; Follicle Stimulating Hormone; Humans; Hypoglycemic Agents; Insulin; Luteinizing Hormone; Menstruation; Metformin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 1998 |
Metformin treatment reduces ovarian cytochrome P-450c17alpha response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Chorionic Gonadotropin; Female; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Ovary; Polycystic Ovary Syndrome; Steroid 17-alpha-Hydroxylase; Testosterone | 2000 |
Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Blood Glucose; Buserelin; Cholesterol; Double-Blind Method; Endocrine Glands; Female; Glucose Clamp Technique; Glucose Tolerance Test; Gonadotropin-Releasing Hormone; Humans; Hypoglycemic Agents; Insulin Resistance; Menstruation Disturbances; Metformin; Polycystic Ovary Syndrome; Triglycerides | 2000 |
Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Area Under Curve; Blood Glucose; C-Peptide; Estradiol; Female; Follicle Stimulating Hormone; Humans; Insulin; Luteinizing Hormone; Menstrual Cycle; Metformin; Obesity; Ovary; Polycystic Ovary Syndrome; Testosterone | 2004 |
Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Body Mass Index; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Luteinizing Hormone; Menstrual Cycle; Metformin; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 2004 |
Metformin for the treatment of hyperandrogenism in adolescents with type 1 diabetes mellitus.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androsterone; Diabetes Complications; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Gonadotropins; Humans; Hyperandrogenism; Hypoglycemic Agents; Metformin; Ovulation | 2013 |
11 other study(ies) available for metformin and 17-alpha-hydroxyprogesterone
| Article | Year |
|---|---|
Insulin and the polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Female; Humans; Hydroxyprogesterones; Hyperandrogenism; Insulin; Luteinizing Hormone; Metformin; Obesity; Polycystic Ovary Syndrome; Steroid 17-alpha-Hydroxylase; Testosterone | 1996 |
The treatment of insulin resistance does not improve adrenal cytochrome P450c17alpha enzyme dysregulation in polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androstenedione; Blood Glucose; Cytochrome P-450 Enzyme System; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Isoenzymes; Metformin; Polycystic Ovary Syndrome | 1999 |
Ovarian responses to hCG stimulation: insulin resistance/hyperinsulinaemia vs. insulin deficiency.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenocorticotropic Hormone; Blood Glucose; Chorionic Gonadotropin; Drug Therapy, Combination; Female; Follicle Stimulating Hormone; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Luteinizing Hormone; Metformin; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Stimulation, Chemical; Testosterone; Time Factors | 1999 |
The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Buserelin; Case-Control Studies; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Luteinizing Hormone; Metformin; Polycystic Ovary Syndrome; Statistics, Nonparametric | 1999 |
Metformin directly inhibits androgen production in human thecal cells.
Topics: 17-alpha-Hydroxyprogesterone; 3-Hydroxysteroid Dehydrogenases; Androgens; Androstenedione; Cells, Cultured; Cholesterol Side-Chain Cleavage Enzyme; Colforsin; Female; Gene Expression Regulation, Enzymologic; Humans; Metformin; Phosphoproteins; Progesterone; RNA, Messenger; Steroid 17-alpha-Hydroxylase; Testosterone; Theca Cells; Transcription, Genetic | 2001 |
Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Blood Glucose; Chorionic Gonadotropin; Estradiol; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Obesity; Ovary; Polycystic Ovary Syndrome; Steroids; Testosterone | 2001 |
[Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome].
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adult; Androgens; Female; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin Resistance; Menstrual Cycle; Metformin; Polycystic Ovary Syndrome | 2001 |
Novel endocrine disrupter effects of classic and atypical antipsychotic agents and divalproex: induction of adrenal hyperandrogenism, reversible with metformin or rosiglitazone.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Adult; Aged; Antipsychotic Agents; Cortodoxone; Dehydroepiandrosterone; Endocrine Disruptors; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Luteinizing Hormone; Male; Metformin; Middle Aged; Radioimmunoassay; Rosiglitazone; Testosterone; Thiazolidinediones; Valproic Acid | 2007 |
The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgens; Androstenedione; Anti-Mullerian Hormone; Body Mass Index; Female; Follicular Phase; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Metformin; Obesity; Polycystic Ovary Syndrome; Testosterone; Waist-Hip Ratio; Young Adult | 2011 |
Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Anti-Mullerian Hormone; Female; Follicular Phase; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Longitudinal Studies; Luteinizing Hormone; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Testosterone; Up-Regulation; Young Adult | 2013 |
The effect of metformin on androgen production in diabetic women with non-classic congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adult; Androgens; Blood Glucose; Dehydroepiandrosterone; Diabetes Mellitus, Type 2; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Metformin; Middle Aged; Testosterone; Treatment Outcome | 2014 |